Cann Group is a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and approved export markets. Cann has established research, cultivation and GMP manufacturing facilities in Bundoora, in northern Melbourne, and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group’s leading position in plant genetics, breeding, extraction, analysis and production techniques supports its objective to supply high quality, safe medicinal cannabis for a range of diseases and medical conditions. Incorporated in the Company's brand portfolio is its proprietary Satipharm delivery system for cannabinoids. Botanitech is a brand created by Cann and boasts a diverse, affordable and high-quality product range. The first stage of our new, state-of-the-art facility in regional Victoria is fully operational, with in-house analytical chemistry and microbiology laboratories, and the capacity to produce 12,500kg of high-quality flower per year, with subsequent stages planned in response to growing demand. We have extensive R&D collaborations with globally renowned agricultural and pharmaceutical research partners, and have developed our own exclusive, proprietary lines of high-yielding cultivars. 
Cann Group is committed to the future of high-quality, low-cost cannabis medicines, and the development of a reliable and trusted industry.

Cannabis

Cann Group

Cann Group's headquarters in Melbourne, Australia

Henry Wang

Steven Notaro

Michael Long

Carlyn Villani

Rob Akkermans

Brigitte Hayes

Judit Tarrés

Angela Volpe

Quality and Microbiology

Cann Group

Org chart

Teams

Quality and Microbiology

Offices

Similar companies